Zobrazeno 1 - 10
of 145
pro vyhledávání: '"O. A. GLADKOV"'
Autor:
M. Yu. Fedyanin, F. V. Moiseenko, M. A. Lyadova, V. N. Vorobyeva, V. V. Petkau, A. V. Fateeva, E. S. Kuzmina, O. Yu. Novikova, V. A. Chubenko, N. Kh. Abduloeva, A. A. Kudryavtsev, E. O. Ignatova, R. R. Shakirov, O. A. Pardabekova, L. V. Kindyalova, S. P. Pelikh, O. A. Gladkov, S. A. Tjulandin, A. A. Tryakin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 1, Pp 11-20 (2021)
Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by “Biocad” (Avegra) in patients with metastatic colon cancer.Materials and methods. This re
Externí odkaz:
https://doaj.org/article/ab81d2b18b6d483387d0ba158a69a3b1
Autor:
A. V. Sultanbaev, R. I. Fatyhov, O. A. Gladkov, M. V. Dvorkin, E. P. Solovieva, S. V. Cheporov, A. S. Loleit, E. I. Ruzavina
Publikováno v:
Medical alphabet. :7-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdd430f334cdccfe097e911eca4cb5c9
https://doi.org/10.33667/2078-5631-2022-31-7-14
https://doi.org/10.33667/2078-5631-2022-31-7-14
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 13-28 (2018)
The high prevalence of BRAF V600 gene mutation in the Russian Federation and the cost of treatment the metastatic melanoma (MM) with immuno-oncology and combined targeted drugs make it relevant to assess the clinical and economic feasibility of their
Externí odkaz:
https://doaj.org/article/dc839ee7e09547fdb913ac18680face4
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 12-24 (2018)
Background. The modern therapies of advanced melanoma include targeted medicines for patients with BRAF mutations. Nowadays, a new perspective on immuno-oncologic medicine pembolizumab became available in Russia. Objective. Assessment of the clinical
Externí odkaz:
https://doaj.org/article/7ac86788063a41b4ac2ea06a10df591c
Autor:
V V Petkau, O A Gladkov, P N Filatov, M V Raigorodskii, A A Tarkhanov, A V Klimushkin, L Yu Nikitina
Publikováno v:
Современная онкология, Vol 20, Iss 1, Pp 46-49 (2018)
The article presents the clinical cases of complex approach to the treatment of patients with advanced hepatocellular carcinoma in everyday clinical practice. The use of targeted therapy with sorafenib and regorafenib lead to the long-term disease co
Externí odkaz:
https://doaj.org/article/714535a9f7bf4e269726b94fab503d69
Autor:
E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatiuk, S. N. Timofeev
Publikováno v:
Креативная хирургия и онкология, Vol 0, Iss 3, Pp 49-52 (2017)
This article provides results of combined modality treatment of patients with stage IIIA(N2) non-small cells lung cancer with systematic and selective lymph node dissection. Elicit that the selective lymph node dissection is valid for patients with s
Externí odkaz:
https://doaj.org/article/e25e94f766664e02be44fd991c5fad94
Autor:
E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatyuk, S. N. Timofeev
Publikováno v:
Сибирский онкологический журнал, Vol 0, Iss 5, Pp 12-16 (2016)
Short-and long-term results of combined modality treatment with systematic (n=60) and selective (n=51) mediastinal lymphodissection were compared in 111 patients with IIIA(N2 ) stage non-small lung cancer taking into account the tumor site, histologi
Externí odkaz:
https://doaj.org/article/57f35e7afda943ca885511b6329fca52
Autor:
O. A. GLADKOV, A. V. SNEGOVOY
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 44-46 (2016)
Anemia is one of the most frequent complications arising in patients with malignant growths, it is characterized by reduction of hemoglobin level and disturbance of a number of physiological and metabolic processes in the organism, impairing the cour
Externí odkaz:
https://doaj.org/article/b33cf0dd5fe94f3fa42d365b20d6b2bb
Autor:
I V Poddubnaya, M R Lichinitser, S A Tyulyandin, V A Gorbunova, V V Ptushkin, M A Abramov, N S Besova, L V Bolotina, I S Bulavina, O A Gladkov, I S Davidenko, L G Zhukova, I A Koroleva, V O Korolenko, G M Manikhas, A V Snegovoy, Yu I Tyukalov, R Sh Khasanov, L N Shigapova
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 50-56 (2011)
Externí odkaz:
https://doaj.org/article/6988344d7af547529dcd0ffe010d684e
Publikováno v:
Medical alphabet. 1:48-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::640215aad3c16082f94a6b5079112264
https://doi.org/10.33667/2078-5631-2019-1-10(385)-48-53
https://doi.org/10.33667/2078-5631-2019-1-10(385)-48-53